TW366286B - Flavour-masked pharmaceutical compositions - Google Patents

Flavour-masked pharmaceutical compositions

Info

Publication number
TW366286B
TW366286B TW081110514A TW81110514A TW366286B TW 366286 B TW366286 B TW 366286B TW 081110514 A TW081110514 A TW 081110514A TW 81110514 A TW81110514 A TW 81110514A TW 366286 B TW366286 B TW 366286B
Authority
TW
Taiwan
Prior art keywords
pharmaceutical compositions
flavour
masked pharmaceutical
masked
medicaments
Prior art date
Application number
TW081110514A
Other languages
English (en)
Inventor
Norbert Poellinger
Johannes Michaelis
Klaus Benke
Roland Rupp
Manfred Buecheler
Original Assignee
Bayer Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6449525&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TW366286(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Healthcare Ag filed Critical Bayer Healthcare Ag
Application granted granted Critical
Publication of TW366286B publication Critical patent/TW366286B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
TW081110514A 1992-01-15 1992-12-31 Flavour-masked pharmaceutical compositions TW366286B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4200821A DE4200821A1 (de) 1992-01-15 1992-01-15 Geschmacksmaskierte pharmazeutische mittel

Publications (1)

Publication Number Publication Date
TW366286B true TW366286B (en) 1999-08-11

Family

ID=6449525

Family Applications (1)

Application Number Title Priority Date Filing Date
TW081110514A TW366286B (en) 1992-01-15 1992-12-31 Flavour-masked pharmaceutical compositions

Country Status (23)

Country Link
US (2) US5695784A (zh)
EP (1) EP0551820B1 (zh)
JP (1) JP3734279B2 (zh)
KR (1) KR100288523B1 (zh)
CN (1) CN1052399C (zh)
AT (1) ATE186212T1 (zh)
AU (1) AU670763B2 (zh)
CA (1) CA2087146C (zh)
CZ (1) CZ283787B6 (zh)
DE (2) DE4200821A1 (zh)
DK (1) DK0551820T3 (zh)
ES (1) ES2141117T3 (zh)
GR (1) GR3032382T3 (zh)
HU (2) HU219592B (zh)
IL (1) IL104362A (zh)
MX (1) MX9207630A (zh)
MY (1) MY111177A (zh)
NZ (1) NZ245658A (zh)
PL (1) PL175569B1 (zh)
RU (1) RU2110255C1 (zh)
SK (1) SK280999B6 (zh)
TW (1) TW366286B (zh)
ZA (1) ZA93234B (zh)

Families Citing this family (85)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4200821A1 (de) * 1992-01-15 1993-07-22 Bayer Ag Geschmacksmaskierte pharmazeutische mittel
DE29502547U1 (de) * 1995-02-16 1995-03-30 Röhm GmbH, 64293 Darmstadt Thermoplastisches Überzugs- und Bindemittel für Arzneiformen
US5840332A (en) * 1996-01-18 1998-11-24 Perio Products Ltd. Gastrointestinal drug delivery system
AUPN969796A0 (en) * 1996-05-07 1996-05-30 F.H. Faulding & Co. Limited Taste masked liquid suspensions
US5766622A (en) * 1996-08-14 1998-06-16 The Procter & Gamble Company Inhibiting undesirable taste in oral compositions
DE19706978A1 (de) * 1997-02-21 1998-08-27 Ulrich Dr Posanski Kombinationspräparat für oral applizierbare Antibiotika
FI111796B (fi) * 1997-05-28 2003-09-30 Finnfeeds Finland Oy Kiinteä betaiinituote, menetelmä sen valmistamiseksi, ja sen käyttö
IN186245B (zh) 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
DE19809719A1 (de) * 1998-03-06 1999-09-09 Roehm Gmbh Wäßrige Dispersion geeignet zur Herstellung von Überzugs- und Bindemitteln für feste orale Arzneiformen
US5976507A (en) * 1998-06-04 1999-11-02 Colgate Palmolive Company Dentrifice composition containing encapsulated reactive ingredients
US6727283B2 (en) * 1998-10-13 2004-04-27 Pfizer Inc. Sertraline oral concentrate
US6723342B1 (en) 1999-02-08 2004-04-20 Fmc Corporation Edible coating composition
US6432448B1 (en) 1999-02-08 2002-08-13 Fmc Corporation Edible coating composition
US6270807B1 (en) * 1999-03-02 2001-08-07 L. Perrigo Company Taste-masked pharmaceutical composition
DE19913692A1 (de) * 1999-03-25 2000-09-28 Basf Ag Mechanisch stabile pharmazeutische Darreichungsformen, enthaltend flüssige oder halbfeste oberflächenaktive Substanzen
GB9911546D0 (en) * 1999-05-19 1999-07-21 Core Technologies Limited Release of poorly soluble agents
DE19930557B4 (de) * 1999-07-02 2005-12-08 Bayer Healthcare Ag Verfahren zur Herstellung von Hydraten von Ciprofloxacin und von Ciprofloxacin-Anhydrat enthaltenden pharmazeutischen Zusammensetzungen
EP1194153B1 (en) 1999-07-09 2004-05-06 Ortho-McNeil Pharmaceutical, Inc. Taste masked pharmaceutical liquid formulations
FR2798289B1 (fr) * 1999-09-15 2004-12-31 Cll Pharma Formes galeniques a delitement rapide en bouche et leur procede de preparation
US6500462B1 (en) 1999-10-29 2002-12-31 Fmc Corporation Edible MCC/PGA coating composition
DK1110550T4 (da) * 1999-12-22 2007-07-02 Dsm Ip Assets Bv Præparat omfattende ascorbinsyre som hovedbestanddel og pektin
DE10026698A1 (de) 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
AU2001275043A1 (en) 2000-05-31 2001-12-11 Drugtech Corporation Mineral supplement
DE10031043A1 (de) * 2000-06-26 2002-02-14 Bayer Ag Retardzubereitungen von Chinolonantibiotika und Verfahren zu ihrer Herstellung
US6932861B2 (en) 2000-11-28 2005-08-23 Fmc Corporation Edible PGA coating composition
EP1339395A2 (en) 2000-11-28 2003-09-03 Fmc Corporation Edible pga (propylene glycol alginate) coating composition
US20020122824A1 (en) * 2001-01-24 2002-09-05 Francisco Cabrera Solid phase dispersion of quinolone-or naphthyridonecarboxylic acids
CA2440069A1 (en) 2001-03-05 2002-09-12 Ortho-Mcneil Pharmaceutical, Inc. Taste masked pharmaceutical compositions
RU2191570C1 (ru) * 2001-04-25 2002-10-27 Закрытое акционерное общество "ВЕРОФАРМ" Твердая лекарственная форма антимикробного средства
JP4705747B2 (ja) * 2001-05-30 2011-06-22 ユーロセルティック ソシエテ アノニム 薬剤組成物
MXPA04001768A (es) * 2001-09-03 2004-11-22 Dsm Ip Assets Bv Composiciones que comprenden pectina y acido ascorbico.
RU2207115C1 (ru) * 2001-12-27 2003-06-27 Закрытое акционерное общество "Брынцалов-А" Противомикробное средство тариферид
WO2003077842A2 (en) * 2002-03-12 2003-09-25 Bristol-Myers Squibb Company Palatable oral suspension and method
AU2003220551A1 (en) * 2002-03-26 2003-10-13 Euro-Celtique S.A. Sustained-release gel coated compositions
MXPA04009968A (es) * 2002-04-09 2004-12-13 Flamel Tech Sa Formulacion farmaceutica oral bajo forma de suspension acuosa de microcapsulas que permiten la liberacion modificada de principio (s) activo (s).
US20030198892A1 (en) * 2002-04-22 2003-10-23 General Electric Company Limited play data storage media and method for limiting access to data thereon
US20030205323A1 (en) * 2002-04-22 2003-11-06 General Electric Company Method for making limited play data storage media
WO2004004682A2 (en) * 2002-07-02 2004-01-15 Laboratorios S.A.L.V.A.T., S.A. Stable oily suspension of microgranules
US20050269722A1 (en) * 2002-07-17 2005-12-08 Stefano De Luigi Brushci Process for the preparation of pharmaceutical microcapsules with enhanced taste-masking and high dissolution rate
US20040208936A1 (en) * 2002-07-22 2004-10-21 Roland Chorin Novel compositions
KR20040011087A (ko) * 2002-07-27 2004-02-05 주식회사 씨티씨바이오 불쾌한 맛과 향을 차폐할 수 있는 록시스로마이신 과립의제조방법
US20040087692A1 (en) * 2002-10-30 2004-05-06 Dixit Arun Nandkishor Method for preparation of an anthraquinone colorant composition
AU2003302881A1 (en) * 2002-12-11 2004-06-30 Ranbaxy Laboratories Limited Coating composition for taste masking coating and methods for their application and use
US20040146553A1 (en) * 2002-12-23 2004-07-29 Aventis Pharma S.A. Compositions for oral administration of active principles requiring masking of taste
US20040170686A1 (en) * 2003-01-31 2004-09-02 Fredrickson Jennifer K. Suspension vehicle for coated drug particles
NZ541681A (en) * 2003-02-10 2009-02-28 Bayer Healthcare Ag Treatment of bacterial diseases of the respiratory organs by locally applying ciprofloxacin and its salts
US20040192781A1 (en) * 2003-03-31 2004-09-30 Haley Eugene T. Method of administration for metoclopramide and pharmaceutical formulation therefor
US20050137265A1 (en) * 2003-03-31 2005-06-23 Haley Eugene T. Rapidly dissolving metoclopramide solid oral dosage and method thereof
US20070059358A1 (en) * 2003-07-02 2007-03-15 Tianjin Tasly Pharmaceutical Co., Ltd., China Matrix adjuvants and the drop pills prepared with them
US7202292B2 (en) * 2003-07-15 2007-04-10 General Electric Company Colored polymeric resin composition with 1,8-diaminoanthraquinone derivative, article made therefrom, and method for making the same
US7087282B2 (en) * 2003-07-15 2006-08-08 General Electric Company Limited play optical storage medium, method for making the same
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
US8377952B2 (en) 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
JP2005343800A (ja) * 2004-05-31 2005-12-15 Lion Corp 被覆カフェイン粒子、固形製剤および眠気防止薬
US7858115B2 (en) * 2004-06-24 2010-12-28 Idexx Laboratories Phospholipid gel compositions for drug delivery and methods of treating conditions using same
US7854943B2 (en) * 2004-06-24 2010-12-21 Idexx Laboratories Phospholipid gel compositions for drug delivery and methods of treating conditions using same
AU2006261314B2 (en) * 2005-06-21 2012-03-22 Merck Patent Gmbh Solid pharmaceutical preparation containing (R)-(-)-2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]chroman
US20080213441A1 (en) * 2006-12-27 2008-09-04 Cathy Jean Ludwig Reduction of Astringency in Polyphenol Compositions
BRPI0701693A2 (pt) * 2007-05-10 2008-12-23 Inst Pesquisas Sao Paulo processo de encapsulaÇço de substÂncias quÍmicamente ativas e produto encapsulado resultante
KR100867639B1 (ko) 2007-06-08 2008-11-10 (주)다산메디켐 고미가 차폐된 염산 도네페질-함유 입자, 이를 포함하는약학 조성물, 및 이들의 제조방법
US8173621B2 (en) 2008-06-11 2012-05-08 Gilead Pharmasset Llc Nucleoside cyclicphosphates
DE102008035542A1 (de) * 2008-07-30 2010-02-04 Siemens Aktiengesellschaft Verfahren zur Ermittlung von Messdaten aus dem Magen eines Patienten
TW201026715A (en) * 2008-12-23 2010-07-16 Pharmasset Inc Nucleoside phosphoramidates
JP6104504B2 (ja) * 2008-12-23 2017-03-29 ギリアド ファーマセット エルエルシー ヌクレオシド類似体
CL2009002206A1 (es) 2008-12-23 2011-08-26 Gilead Pharmasset Llc Compuestos derivados de pirrolo -(2-3-d]-pirimidin-7(6h)-tetrahidrofuran-2-il fosfonamidato, composicion farmaceutica; y su uso en el tratamiento de enfermedades virales.
TWI583692B (zh) 2009-05-20 2017-05-21 基利法瑪席特有限責任公司 核苷磷醯胺
JP2012528799A (ja) 2009-06-02 2012-11-15 ダウ グローバル テクノロジーズ エルエルシー 徐放製剤
KR101765357B1 (ko) * 2009-12-02 2017-08-04 아데어 파마수티컬스 에스.알.엘. 펙소페나딘 마이크로캡슐 및 그것을 함유하는 조성물
US20110236494A1 (en) * 2010-03-04 2011-09-29 Ranbaxy Laboratories Limited Ciprofloxacin oral suspension
CL2011000716A1 (es) 2010-03-31 2012-04-20 Gilead Pharmasset Llc Formas cristalinas 1 6 de (s)-isopropil-2-(((s)-(((2r.3r.4r.5r)-5-(2,4-dioxo-3,4-dihidropirimidin-1(2h)-il)-4-fluoro-3-hidroxi-4-metil tetrahidrofuran-2-il)metoxi)(fenoxi)fosforil)amino)propanoato; composicion y combinacion farmaceutica; y su uso para tratar una infeccion por el virus de la hepatitis c.
UY33312A (es) 2010-03-31 2011-10-31 Pharmasset Inc Fosforamidato de nucleosido de purina
PL3290428T3 (pl) 2010-03-31 2022-02-07 Gilead Pharmasset Llc Tabletka zawierająca krystaliczny (S)-2-(((S)-(((2R,3R,4R,5R)-5-(2,4-diokso-3,4-dihydropirymidyn-1(2H)-ylo)-4-fluoro-3-hydroksy-4-metylotetrahydrofuran-2-ylo)metoksy)(fenoksy)fosforylo)amino)propanian izopropylu
PT2558079T (pt) * 2010-04-12 2019-09-05 S Zhaveri Pharmakem Pvt Ltd Composição de xarope seco de ciprofloxacina
CN101985044B (zh) * 2010-07-16 2013-10-23 钟术光 一种掩味的药物涂层组合物
WO2012075140A1 (en) 2010-11-30 2012-06-07 Pharmasset, Inc. Compounds
CN102526124B (zh) * 2011-01-31 2013-11-20 成都科尔医药技术有限公司 一种中药粉体及其制备方法
AR089646A1 (es) 2011-08-12 2014-09-10 Boehringer Ingelheim Vetmed Inhibidores de corrientes funny (if) para utilizar en un metodo de tratamiento y prevencion de la insuficiencia cardiaca en felinos
WO2014144661A1 (en) 2013-03-15 2014-09-18 Aprecia Pharmaceuticals Compny Rapidly dispersible dosage form of topiramate
CA2906107C (en) 2013-03-15 2021-08-24 Aprecia Pharmaceuticals Company Rapidly dispersible dosage form of oxcarbazepine
RU2599007C1 (ru) * 2015-08-24 2016-10-10 Александр Александрович Кролевец Способ получения нанокапсул ципрофлоксацина гидрохлорида в альгинате натрия
ITUB20155193A1 (it) * 2015-11-03 2017-05-03 Italfarmaco Spa Sospensioni orali di Givinostat fisicamente e chimicamente stabili
CN105343028B (zh) * 2015-11-25 2018-08-21 万邦德制药集团股份有限公司 一种诺氟沙星的药物组合物及其制备方法
WO2020104837A1 (en) 2018-11-21 2020-05-28 Rosemont Pharmaceuticals Limited Oral topiramate suspension formulations with extended shelf stability and enhanced bioavailability
US20220233580A1 (en) * 2019-05-28 2022-07-28 Toymedical Co., Ltd. Sodium excretion particles
CN116459222A (zh) * 2023-04-20 2023-07-21 山东中医药大学附属医院 一种匹维溴铵组合物、制剂及其用途

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8203953D0 (sv) * 1982-06-24 1982-06-24 Astra Laekemedel Ab Pharmaceutical mixture
US4994260A (en) * 1982-05-28 1991-02-19 Astra Lakemedel Aktiebolag Pharmaceutical mixture
DE3808277A1 (de) * 1988-03-12 1989-09-21 Bayer Ag Verfahren und vorrichtung zur wirbelschichtspruehgranulation
EP0163836B1 (de) * 1984-04-07 1988-10-12 Bayer Ag Verfahren und Vorrichtung zur Herstellung von Granulaten
US4639458A (en) * 1985-01-22 1987-01-27 Merck & Co., Inc. Tablet and formulation
US4971791A (en) * 1985-08-26 1990-11-20 The Procter & Gamble Company Taste masking compositions
US4764375A (en) * 1985-09-11 1988-08-16 Kv Pharmaceutical Company Sachet drug delivery system
EP0230811B1 (fr) * 1986-01-24 1992-06-03 Valeo Electronique Bobine d'allumage à circuit fermé
SE8605515D0 (sv) * 1986-12-22 1986-12-22 Astra Laekemedel Ab A liquid dosage form for oral administration of a pharmaceutically active substance
FI77573C (fi) * 1987-05-08 1989-04-10 Orion Yhtymae Oy Ny konsistens.
NL193682C (nl) * 1987-05-14 2000-07-04 Glaxo Group Ltd Beklede cefuroximaxetilsamenstelling.
IE59934B1 (en) * 1987-06-19 1994-05-04 Elan Corp Plc Liquid suspension for oral administration
GB8723896D0 (en) * 1987-10-12 1987-11-18 Aps Research Ltd Controlled-release formulation
DE3808116A1 (de) * 1988-03-11 1989-09-21 Bayer Ag Zick-zack-sichter
DE3900811A1 (de) * 1989-01-13 1990-07-19 Kali Chemie Pharma Gmbh Neue arzneiform
DE3920082A1 (de) * 1989-06-20 1991-03-07 Roehm Gmbh Filmbildendes waessriges ueberzugsmittel fuer feste arzneimittel, verfahren zu seiner herstellung und verwendung
US5082669A (en) * 1989-07-20 1992-01-21 Dainippon Pharmaceutical Co., Ltd. Rapid-releasing oral particle pharmaceutical preparation with unpleasant taste masked
ZA923474B (en) * 1991-05-20 1993-01-27 Marion Merrell Dow Inc Diltiazem formulation
DE4200821A1 (de) * 1992-01-15 1993-07-22 Bayer Ag Geschmacksmaskierte pharmazeutische mittel

Also Published As

Publication number Publication date
AU670763B2 (en) 1996-08-01
SK372092A3 (en) 1995-05-10
IL104362A (en) 1997-04-15
RU2110255C1 (ru) 1998-05-10
US6136347A (en) 2000-10-24
CA2087146C (en) 2003-03-18
GR3032382T3 (en) 2000-04-27
ES2141117T3 (es) 2000-03-16
AU3113893A (en) 1993-07-22
PL175569B1 (pl) 1999-01-29
ZA93234B (en) 1993-08-16
HUT64693A (en) 1994-02-28
MX9207630A (es) 1993-07-30
PL297399A1 (en) 1993-08-09
DE59309858D1 (de) 1999-12-09
DK0551820T3 (da) 2000-04-25
HU219592B (hu) 2001-05-28
ATE186212T1 (de) 1999-11-15
HK1005987A1 (zh) 1999-02-05
IL104362A0 (en) 1993-05-13
US5695784A (en) 1997-12-09
EP0551820A1 (de) 1993-07-21
CZ372092A3 (en) 1993-08-11
DE4200821A1 (de) 1993-07-22
MY111177A (en) 1999-09-30
CZ283787B6 (cs) 1998-06-17
NZ245658A (en) 1995-02-24
CN1052399C (zh) 2000-05-17
HU9300085D0 (en) 1993-04-28
JP3734279B2 (ja) 2006-01-11
EP0551820B1 (de) 1999-11-03
CN1074603A (zh) 1993-07-28
HU211154A9 (en) 1995-10-30
KR100288523B1 (ko) 2001-09-17
JPH05255072A (ja) 1993-10-05
SK280999B6 (sk) 2000-10-09
CA2087146A1 (en) 1993-07-16

Similar Documents

Publication Publication Date Title
MY111177A (en) Flavour-masked pharmaceutical compositions
NZ501950A (en) Medicinal compositions for application to mucosa
CA2024916A1 (en) Respiratory disorder medicaments comprising salmeterol and fluticasone propionate
MY118371A (en) Tetrahydrolipstatin containing compositions
CA2180816A1 (en) 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutical active ingredients
CA2193337A1 (en) 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol compounds as pharmaceutical active ingredients
FI962154A0 (fi) Koostumus terapeuttisten tuotteiden in vivo valmistusta varten
EP1161956A4 (en) DRUG COMPOSITIONS
HK94390A (en) Pharmaceutical compositions containing anthracycline glycosides
CS653586A3 (en) Pharmaceutical containing 7-isopropoxyisoflavone
IL110045A (en) Pharmaceutical compositions containing oligopeptides for combating AIDS and ARC and for immune stimulation and certain such novel oligopeptides
CA2404387A1 (en) Theanine compositions for promoting sleep
GB2316004B (en) Novel formulations for transdermal delivery of pergolide
PT74586B (en) Process for the preparation emulsions of the tyre oil-in-water specially appropriate for being used as formulations of agro- chemical compositions for combating pests in the domestic field and hygiene field and/or of pharmaceutical compositions
CA2024872A1 (en) Medicaments
RU95101385A (ru) Продукты, содержащие g-csf и tnf связующие протеина
WO1996022305A3 (en) Modified peptides
CY1858A (en) Pharmaceutical preparation for the systemic treatment of toy fish and domestic fish
ATE347886T1 (de) Arzneizubereitungen enthaltend paclitaxel eingeschlossen in nanopartikeln von polymerischen mizellen
GB0018322D0 (en) Pharmaceutical compositions
EP0272393A3 (en) Pharmaceutical combination
EP0190860A3 (en) 6-chloro-3-methyl-1h-2,3,4,5-tetrahydro-3-benzazepine-n-oxide and medical compositions using it
AU6037494A (en) Use of active substances in the therapy of certain diseases, process for preparing a pharmaceutical composition for that purpose and pharmaceutical compositions thus prepared
BR0116373A (pt) Utilização de tienilciclo-hexilamina, produto, e, composições farmacêuticas
RU92004541A (ru) Лекарственные средства для лечения воспалительных состояний или для аналгезии